Quellen:
Armstrong, Paul W et al. “Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat.” JACC. Heart failure vol. 10,9 (2022): 677-688. doi:10.1016/j.jchf.2022.04.015
https://pubmed.ncbi.nlm.nih.gov/36049817/
Mohebi, Reza et al. “Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.” Journal of the American College of Cardiology vol. 80,16 (2022): 1529-1541. doi:10.1016/j.jacc.2022.08.737
https:/pubmed.ncbi.nlm.nih.gov/36229089/